Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
about
Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.Heparanase: From basic research to therapeutic applications in cancer and inflammation.Structure Activity Relationship of Heparin Mimicking Polymer p(SS-co-PEGMA): Effect of Sulfonation and Polymer Size on FGF2-Receptor Binding.Heparin Mimetics: Their Therapeutic Potential.
P2860
Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antitumor efficacy of the hepa ...... of receptor tyrosine kinases.
@en
Antitumor efficacy of the heparan sulfate mimic roneparstat
@nl
type
label
Antitumor efficacy of the hepa ...... of receptor tyrosine kinases.
@en
Antitumor efficacy of the heparan sulfate mimic roneparstat
@nl
prefLabel
Antitumor efficacy of the hepa ...... of receptor tyrosine kinases.
@en
Antitumor efficacy of the heparan sulfate mimic roneparstat
@nl
P2093
P2860
P50
P356
P1433
P1476
Antitumor efficacy of the hepa ...... of receptor tyrosine kinases.
@en
P2093
Enrica Favini
Franco Zunino
Laura Dal Bo
Marcella De Maglie
Monica Tortoreto
Silvana Pilotti
P2860
P304
47848-47863
P356
10.18632/ONCOTARGET.10292
P407
P577
2016-06-25T00:00:00Z